Research
And Grants
Note: When clicking the "Submit Grant Application" button below you will be redirected to SnapGrant.com to complete the application process.
Submit Grant ApplicationThe Cure Starts Now follows an extensive grant approval process to ensure your dollars make the biggest impact to homerun cancer research. Take comfort in knowing that The Cure Starts Now only funds: research that follows our mission, research that is non-duplicative, and research that is financially sound.
The Cure Starts Now has funded $24,934,877 (USD) in pediatric brain cancer research in partnership with the DIPG / DMG Collaborative. This includes 161 grants at over 100 hospitals in 29 countries.
Children's Healthcare of Atlanta – $100,000
$100,000.00
November 2024
Radiation Resistance in Medulloblastoma
University of Texas Health Science Center at San Antonio – $100,000
$100,000.00
November 2024
Targeting Metabolic Vulnerabilities for Treating Medulloblastoma
University of Texas Health Science Center at San Antonio – $50,000
$50,000.00
November 2024
Targeting RRNA Modification and SNORNA Function, A Novel Concept to Treat Aggressive Medulloblastoma
Children’s National Medical Center – $300,000
$300,000.00
November 2024
Multilamellar H3K27M RNA aggregates targeting diffuse midline glioma, including diffuse intrinsic pontine glioma.
Children's Hospital Los Angeles – $100,000
$100,000.00
October 2024
Targeting FOXR2 in Diffuse Midline Gliomas
University Hospital of Navarra - $100,000 USD, €92,637 EUR
$100,000.00
October 2024
Targeting Diffuse Midline Glioma vulnerabilities as a therapeutic strategy.
The Institute of Cancer Research – $111,445 USD / £85,976 GBP
$111,445.00
October 2024
Unravelling transcriptional plasticity as a non-genetic mechanism of drug resistance in DMG.
Children’s Cancer Institute – $100,000 USD / $150,589 AUD
$100,000.00
October 2024
Targeting lactate production pathways as a novel therapy against DIPG
Sydney Children's Hospital - Randwick – $196,577 USD / $296,025.11 AUD
$196,577.00
October 2024
Unlocking the potential of the blood-brain barrier in the fight against paediatric brain gliomas.
McGill University - $100,000
$100,000.00
October 2024
Understanding tumor heterogeneity and characterizing treatment responses in ACVR1-mutated diffuse midline gliomas.
Cincinnati Children’s Hospital Medical Center - $200,000
$200,000.00
October 2024
Combining FLASH and immunotherapy to target medulloblastoma relapse
Emory University / Cincinnati Children's Hospital – $93,250
$93,250.00
March 2024
SUMOylation as a novel therapeutic target in DIPG
University of Chicago Medical Center / Washington University St. Louis – $100,000
$100,000.00
December 2023
Characterizing and Targeting ABL1 and ABL2 in Medulloblastoma Leptomeningeal Dissemination.
Icahn School of Medicine at Mount Sinai – $100,000
$100,000.00
December 2023
Targeting macrophages to improve the survival of DIPG
Children’s Cancer Institute – $50,000
$50,000.00
December 2023
A novel formulation to allow the simultaneous targeting of MYCN expression and copper chelation to treat DIPG tumour and overcome multidrug resistance.